The Book of Pharmaceutical & Healthcare Lists

Information is the life blood of the pharmaceutical industry. Companies rely heavily on massive volumes of data to demonstrate the safety and efficacy of medicines submitted for registration, monitor adverse events and side-effects under strict post-marketing surveillance requirements, certify the cost effective performance of marketed products in improving public health outcomes, and protect patents, trademarks and other forms of intellectual property.
The challenge, however, is finding ways to make all this information accessible to others. The Book of Pharmaceutical and Healthcare Lists is the accessible answer to this essential question, serving as the entry point for anyone – from researchers to journalists to the general public, including patients – who needs help in transforming data and information into knowledge. It includes over 150 lists covering virtually every aspect of today’s biopharmaceutical business model, regulatory and policy arena, including worldwide health statistics, data on global pharmaceutical markets and marketing, and pharmaceutical and biotechnology innovation, as well as data on medication use and expenditures among the US population.
It is a reference source with diverse practical uses – from reinforcing the findings of a peer-reviewed clinical study, to providing background information and facts for journalists and speechwriters, marketers and advertisers, as well as students in public health, health administration and health policy.